PlateReady™ HepG2

PlateReady™ HepG2 Well Plates contain HepG2 cells cryopreserved directly adhered to microplates using CryoLogyx’s patented CryoShield™ formulation. Follow our three-step General Thaw-and-Use Protocol to ensure that PlateReady™ HepG2 Well Plates perform comparably to freshly cultured cells 24 hours post-thaw in viability, functional, and drug-dose response assays.

Assay-ready 24 hours post-thaw - immediate proliferative capacity, metabolic activity and membrane integrity

  • PlateReady™ HepG2 Plates contains human hepatocellular carcinoma derived cells cryopreserved directly adhered to microplates with the use of CryoLogyx’s patented CryoShield™ formulation. HepG2 cells perform many differentiated hepatic functions, making them the most widely used cell line in drug discovery for drug metabolism and hepatotoxicity testing.

  • PlateReady™ HepG2 Well Plates are provided at three different confluency levels:
    Low: < 30% surface coverage.

    Medium: 40 – 60% cell surface coverage.

    High: > 70% cell surface coverage.

  • 24-well
    96-well

  • HPG20096PSCLHIG - High confluency, 96 microplate

    HPG20096PSCLMID - Medium confluency, 96 microplate

    HPG20096PSCLLOW - Low confluency, 96 microplate

    HPG20024PSCLHIG - High confluency, 24 microplate

    HPG20024PSCLMID - Medium confluency, 24 microplate

    HPG20024PSCLLOW - Low confluency, 24 microplate

  • -80°C Freezer. Use by the expiry date on the packaging.

  • Eagle's minimum essential medium supplemented with 10% fetal bovine serum, 1% MEM non-essential amino acids and 1% antibiotic-antimyotic solution (optional).

Contact us.

High-quality content, relevant news and updates. No spam, only once a month! Unsubscribe anytime.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.